D'Tiole v. Hhs ( 2018 )


Menu:
  •       NOTE: This disposition is nonprecedential.
    United States Court of Appeals
    for the Federal Circuit
    ______________________
    MYKELLE JIVON D'TIOLE,
    Petitioner-Appellant
    v.
    SECRETARY OF HEALTH AND HUMAN
    SERVICES,
    Respondent-Appellee
    ______________________
    2017-1982
    ______________________
    Appeal from the United States Court of Federal
    Claims in No. 1:15-vv-00085-EJD, Senior Judge Edward
    J. Damich.
    ______________________
    Decided: April 12, 2018
    ______________________
    CURTIS RANDAL WEBB, Twin Falls, ID, argued for
    petitioner-appellant.
    ROBERT PAUL COLEMAN, III, Vaccine/Torts Branch,
    Civil Division, United States Department of Justice,
    Washington, DC, argued for respondent-appellee. Also
    represented by CHAD A. READLER, C. SALVATORE
    2                                           D'TIOLE   v. HHS
    D’ALESSIO, CATHARINE E. REEVES, GABRIELLE                M.
    FIELDING, LARA A. ENGLUND.
    ______________________
    Before MOORE, LINN, and CHEN, Circuit Judges.
    LINN, Circuit Judge.
    The parents and relatives of Mykelle Jivon D’Tiole
    (collectively “D’Tiole”) appeal from the decision of the
    Court of Federal Claims under the National Childhood
    Vaccine Injury Act of 1986 (“Vaccine Act”), affirming the
    determination by Special Master Brian H. Corcoran
    denying compensation for narcolepsy with cataplexy
    allegedly caused by administration of the FluMist vaccine.
    D’Tiole v. Sec’y of Health & Human Servs., (“Special
    Master Op.”) No. 15-85, 
    2016 WL 7664475
    , 2016 U.S.
    claims LEXIS 2003 (Fed. Cl. Nov. 28, 2016), aff’d 132 Fed.
    Cl. 421 (2017).
    Because the Special Master’s decision was not arbi-
    trary, capricious, or an abuse of discretion, was legally
    proper, see 42 U.S.C. § 300aa-12(e)(2)(B), and was based
    on a plausible analysis of the record evidence, we affirm.
    We write for the parties, and therefore omit the factual
    and procedural background from this opinion.
    A.
    In Althen v. Sec’y of Health & Human Services, 
    418 F.3d 1274
    (Fed. Cir. 2005) and Capizzano v. Sec’y of
    Health and Human Services, 
    440 F.3d 1317
    (Fed. Cir.
    2006), this court made clear that the Vaccine Act man-
    dates proof of causation by a “preponderance of the evi-
    dence,” 42 U.S.C. § 300aa-12(a)(1), “substantiated by
    medical records or medical opinion,” 
    Althen, 418 F.3d at 1279
    , but does not “require” medical documentation to
    prove causation. 
    Id. at 1280,
    1281 (“To require Althen to
    provide medical documentation would contravene the
    D'TIOLE   v. HHS                                        3
    plain language of the statute.”). See also 
    Capizzano, 440 F.3d at 1325
    .
    D’Tiole argues that the Special Master violated Althen
    and Capizzano by de facto requiring epidemiological
    evidence because the Special Master gave undue weight
    to Duffy 1 and did not give enough weight to the Han 2
    studies.
    The Special Master considered Duffy as strong evi-
    dence against Dr. Steinman’s theory that the evidence
    linking Pandemrix (a vaccine using an inactivated form of
    H1N1) to narcolepsy via molecular mimicry also estab-
    lished a medical theory causally connecting FluMist (a
    Live Attenuated Influenza Vacccine (“LAIV”)) to narcolep-
    sy. In coming to that conclusion, the Special Master
    explained the baseline deficiency in Dr. Steinman’s theo-
    ry. The scientific literature indicated that the form of
    manufacture of the inactive flu vaccine was likely in-
    volved in the association of Pandemrix with narcolepsy.
    Dr. Steinman’s theory fails to explain how this evidence
    applies to the FluMist vaccine, which has a distinct
    formulation and manufacturing process.
    The consideration of Duffy did not de facto improperly
    require D’Tiole to provide epidemiological data to prove
    causation. The Special Master explicitly wrote that he
    was not requiring epidemiological evidence.       Special
    Master Op. at 29 (“As a general matter, it is true that
    Program petitioners need not offer epidemiological evi-
    dence to establish their causation burden under Althen.
    1    Duffy J., et al., “Narcolepsy and Influenza
    A(H1N1) pandemic 2009 in the United States,” Neurology,
    83: 1823–1830 (2014) (“Duffy”)
    2   Han F, et al., “Narcolepsy onset is seasonal and
    increased following the H1N1 pandemic in China,” Ann.
    Neurol, 70(3): 410-417 (September 2011).
    4                                              D'TIOLE   v. HHS
    Indeed, because vaccine injuries are rare events, the fact
    that a particular epidemiological study suggests a vaccine
    is generally safe should not prevent a claimant from
    prevailing.”); 
    id. at 27
    (“By petitioner’s admission, there is
    no direct evidence of [causation] (although that fact does
    not mean the claim could not succeed, given the ac-
    ceptance in the [Vaccine] Program of the notion that
    vaccine injuries are rare and otherwise need not be prov-
    en with scientific certainty.”)). Indeed, the Special Master
    noted possible probative evidence that would render
    D’Tiole’s case stronger. 
    Id. at 31
    (“Petitioner’s theory
    could well become more reliable once there is stronger
    proof linking the LAIV form of the H1N1 flu vaccine, or
    better and more consistent evidence linking the H1N1
    wild virus alone, to narcolepsy. Studies measuring the
    nucleoprotein antibody levels in individuals vaccinated
    with FluMist would also be useful in supporting the
    theory.”). The Special Master’s acceptance of Duffy’s
    finding of a lack of a correlation between an LAIV vaccine
    and narcolepsy as undermining Dr. Steinman’s theory, 
    id. at 29
    (“[T]he Duffy epidemiologic study stood as very
    strong evidence rebutting an association between an
    LAIV containing the H1N1 strain and narcolepsy.”) did
    not directly or implicitly require epidemiological proof of
    causation. To the contrary, it simply reflects the Special
    Master’s assessment of the record presented.
    Nothing in Althen or Capizzano requires the Special
    Master to ignore probative epidemiological evidence that
    undermines petitioner’s theory. See Andreu v. Health &
    Human Servs., 
    569 F.3d 1367
    , 1379 (Fed. Cir. 2009)
    (“Although Althen and Capizzano make clear that a
    claimant need not produce medical literature or epidemio-
    logical evidence to establish causation under the Vaccine
    Act, where such evidence is submitted, the Special Master
    can consider it in reaching an informed judgment as to
    whether a particular vaccination likely caused a particu-
    lar injury.” (emphasis added)); Grant v. Health & Human
    D'TIOLE   v. HHS                                          5
    Servs., 
    956 F.2d 1144
    , 1148-49 (Fed. Cir. 1992) (consider-
    ing negative epidemiological studies). The Special Mas-
    ter’s reliance on Duffy did not improperly raise the
    standard in Althen beyond a preponderance of the evi-
    dence.
    The Special Master also adequately explained that
    there were “facial difficulties with giving [Han] too much
    weight.” The Special Master noted specifically that, as
    recognized in Dr. Steinman’s co-authored Ahmed II arti-
    cle, the results in Han were not duplicated outside of
    China and may have been the result of the high residen-
    tial density in Hong Kong rather than the virus itself.
    Special Master Op. at 28. “[W]e do not sit to reweigh the
    evidence.” Lampe v. Sec’y of Health & Human Servs., 
    219 F.3d 1357
    , 1363 (Fed. Cir. 2000) (explaining that where
    the Special Master’s “conclusion was based on evidence in
    the record that was not wholly implausible, we are com-
    pelled to uphold that finding as not being arbitrary or
    capricious.”).
    B.
    D’Tiole also argues that the Special Master abused his
    discretion by deciding the case without an evidentiary
    hearing. We do not agree.
    The decision to hold an evidentiary hearing is statuto-
    rily committed to the discretion of the Special Master.
    See 42 U.S.C. § 300aa-12(d)(3)(B)(v) (Special Master “may
    conduct such hearings as may be reasonable and neces-
    sary”). Nothing obliges the Special Master to hold such a
    hearing. 
    Id. Here, the
    Special Master afforded D’Tiole a
    full and fair opportunity to present its case as required by
    Vaccine Rule 3(b) by accepting and considering seven
    expert reports, which addressed each of the arguments
    presented by both parties. See Special Master Op. at 37.
    D’Tiole does not point to any particular issues that the
    expert reports did not cover. The Special Master ade-
    quately explained that the primary issue—the presence or
    6                                           D'TIOLE   v. HHS
    absence of a reasonable theory of causation between the
    LIAV FluMist vaccine and narcolepsy—would be deter-
    mined wholly based on the strength of the scientific
    evidence and the content of the seven expert reports, and
    not on any credibility determinations for which an eviden-
    tiary hearing could be helpful. D’Tiole has simply failed
    to show any abuse of discretion in this determination.
    The Special Master’s determination was not arbitrary,
    capricious or an abuse of discretion, was legally proper,
    see 42 U.S.C. § 300aa-12(e)(2)(B), and was based on a
    plausible analysis of the record evidence.
    AFFIRMED
    COSTS
    No costs.